UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 5 | May 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 10 Issue 12
December-2023
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2312608


Registration ID:
530625

Page Number

g47-g57

Share This Article


Jetir RMS

Title

Review On Diabetes Insipidus

Abstract

Many disorders affecting the hypothalamic-neurohypophyseal system can lead to central diabetes insipidus (CDI). Germininoma/craniopharyngioma, Langerhans cell histiocytosis (LCH), vascular, autoimmune, or local inflammatory diseases; trauma from surgery or an accident; sarcoidosis; metastases; and midline cerebral and cranial malformations are among the known causes. Rarely, X-linked recessive, autosomal dominant, or autosomal recessive genetic abnormalities in vasopressin synthesis may be the underlying cause. Given that the underlying condition requires long-term follow-up, the diagnosis is difficult and causes anxiety in both patients and parents. The process of achieving an accurate etiological diagnosis involves a number of steps, beginning with clinical observations and moving on to more advanced instruments. The most notable findings that have contributed to the diagnosis and understanding of neurohypophyseal functional integrity have been obtained specifically from the MRI identification of pituitary hyperintensity in the posterior part of the sella, which is now recognized as a clear marker of neurohypophyseal functional integrity, and the meticulous examination of pituitary stalk shape and size. If left untreated, diabetes insipidus, which is characterized by large amounts of diluted urine excretion, can be fatal. It can be brought on by one of two essentially distinct defects: either impaired or insufficient renal response to ADH (nephrogenic diabetes insipidus) or inadequate or impaired secretion of antidiuretic hormone (ADH) from the posterior pituitary gland (neurogenic or central diabetes insipidus). Making the distinction is necessary for treatment to be effective. Antidiuretic hormone (ADH), a posterior pituitary peptide hormone, is involved in diabetes insipidus.

Key Words

Central diabetes insipidus _ Langerhans cell histiocytosis _Pituitary stalk _ Vasopressin central diabetes insipidus.

Cite This Article

"Review On Diabetes Insipidus", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 12, page no.g47-g57, December-2023, Available :http://www.jetir.org/papers/JETIR2312608.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Review On Diabetes Insipidus", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 12, page no. ppg47-g57, December-2023, Available at : http://www.jetir.org/papers/JETIR2312608.pdf

Publication Details

Published Paper ID: JETIR2312608
Registration ID: 530625
Published In: Volume 10 | Issue 12 | Year December-2023
DOI (Digital Object Identifier):
Page No: g47-g57
Country: Thane, Maharashtra , India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00052

Print This Page

Current Call For Paper

Jetir RMS